A critical review on modulators of Multidrug Resistance Protein 1 in cancer cells
Open Access
Abstract
Multidrug resistance protein 1 (MRP1/ABCC1) is an ATP-dependent efflux transporter, and responsible for the transport of a broad spectrum of xenobiotics, toxins, and physiological substrates across the plasma membrane. As an efflux pump, it plays a significant role in the absorption and disposition of drugs including anticancer drugs, antivirals, antimalarials, and antibiotics and their metabolites across physiological barriers in cells. MRP1 is also known to aid in the regulation of several physiological processes such as redox homeostasis, steroid metabolism, and tissue defense. However, its overexpression has been reported to be a key clinical marker associated with multidrug resistance (MDR) of several types of cancers including lung cancer, childhood neuroblastoma, breast and prostate carcinomas, often resulting in a higher risk of treatment failure and shortened survival rates in cancer patients. Aside MDR, overexpression of MRP1 is also implicated in the development of neurodegenerative and cardiovascular diseases. Due to the cellular importance of MRP1, the identification and biochemical/molecular characterization of modulators of MRP1 activity and expression levels are of key interest to cancer research and beyond. This review primarily aims at highlighting the physiological and pharmacological importance of MRP1, known MRP1 modulators, current challenges encountered, and the potential benefits of conducting further research on the MRP1 transporter.Keywords
This publication has 137 references indexed in Scilit:
- MicroRNAs and Cancer TherapeuticsPharmaceutical Research, 2011
- Expression and Function of Human MRP1 (ABCC1) Is Dependent on Amino Acids in Cytoplasmic Loop 5 and Its Interface with Nucleotide Binding Domain 2Journal of Biological Chemistry, 2011
- Membrane transport proteins in human melanoma: associations with tumour aggressiveness and metastasisBritish Journal of Cancer, 2010
- Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1Biochemical Pharmacology, 2010
- Mice lacking Mrp1 have reduced testicular steroid hormone levels and alterations in steroid biosynthetic enzymesGeneral and Comparative Endocrinology, 2010
- The Pharmacogenomics of Membrane Transporters Project: Research at the Interface of Genomics and Transporter PharmacologyClinical Pharmacology & Therapeutics, 2009
- Plasma membrane glutathione transporters and their roles in cell physiology and pathophysiologyMolecular Aspects of Medicine, 2009
- Multidrug resistance-associated protein 9 (ABCC12) is present in mouse and boar spermBiochemical Journal, 2007
- Targeting multidrug resistance in cancerNature Reviews Drug Discovery, 2006
- Molecular mechanisms of drug resistanceThe Journal of Pathology, 2005